Project Details
Description
Cancer in Luxembourg is a major public health issue. It is estimated that 18,000 people are currently living with cancer in the Grand Duchy, and that each year 3,000 new people are diagnosed. The most common cancers are breast cancer for women and prostate cancer for men, followed by lung cancer and colorectal cancer for both sexes. Numerous initiatives and action plans have been implemented in Luxembourg with the aim of supporting and improving the national fight against cancer: prevention campaigns, organised screening operations, epidemiological cancer surveillance (National Cancer Registry – RNC), creation of foundations and support associations, development of fundamental and clinical research, as well as the introduction of the National Cancer Plan, which is repeated periodically every 4 years. However, to date, we do not have data on the overall experience of cancer patients treated in Luxembourg, which is essential for the evaluation and improvement of the Luxembourg health system.
The Colive Cancer study, which is part of the second National Cancer Plan (2020-2024), aims to make this progress possible by gathering relevant information from the experiences of patients treated for cancer in the Grand Duchy. Through this study, we want to evaluate the current cancer care system in Luxembourg, based on the direct experience of patients. We hope that around 500 people will participate in this survey. In addition, we also aim to:
• Measuring socio-economic inequalities in relation to this disease,
• Assessing access to information throughout the cancer journey,
• To determine the impact of prevention campaigns in Luxembourg.
Finally, we want to identify vocal biomarkers of common symptoms in cancer. Voice biomarkers are characteristics in the voice that can be related to our health status. Identifying such vocal biomarkers would eventually allow the development of solutions for remote monitoring of disease progression, symptoms or side effects of treatment. This would allow advances in the adaptation and personalisation of treatment and care, thus improving the quality of life of patients.
The Colive Cancer study, which is part of the second National Cancer Plan (2020-2024), aims to make this progress possible by gathering relevant information from the experiences of patients treated for cancer in the Grand Duchy. Through this study, we want to evaluate the current cancer care system in Luxembourg, based on the direct experience of patients. We hope that around 500 people will participate in this survey. In addition, we also aim to:
• Measuring socio-economic inequalities in relation to this disease,
• Assessing access to information throughout the cancer journey,
• To determine the impact of prevention campaigns in Luxembourg.
Finally, we want to identify vocal biomarkers of common symptoms in cancer. Voice biomarkers are characteristics in the voice that can be related to our health status. Identifying such vocal biomarkers would eventually allow the development of solutions for remote monitoring of disease progression, symptoms or side effects of treatment. This would allow advances in the adaptation and personalisation of treatment and care, thus improving the quality of life of patients.
| Status | Active |
|---|---|
| Effective start/end date | 1/01/22 → 31/12/25 |
Funding
- Ministry of Health: €397,155.00
- Ministry of Health: €380,000.00
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.